172 related articles for article (PubMed ID: 11052794)
1. N,N-Diethyl-4-(phenylpiperidin-4-ylidenemethyl)benzamide: a novel, exceptionally selective, potent delta opioid receptor agonist with oral bioavailability and its analogues.
Wei ZY; Brown W; Takasaki B; Plobeck N; Delorme D; Zhou F; Yang H; Jones P; Gawell L; Gagnon H; Schmidt R; Yue SY; Walpole C; Payza K; St-Onge S; Labarre M; Godbout C; Jakob A; Butterworth J; Kamassah A; Morin PE; Projean D; Ducharme J; Roberts E
J Med Chem; 2000 Oct; 43(21):3895-905. PubMed ID: 11052794
[TBL] [Abstract][Full Text] [Related]
2. New diarylmethylpiperazines as potent and selective nonpeptidic delta opioid receptor agonists with increased In vitro metabolic stability.
Plobeck N; Delorme D; Wei ZY; Yang H; Zhou F; Schwarz P; Gawell L; Gagnon H; Pelcman B; Schmidt R; Yue SY; Walpole C; Brown W; Zhou E; Labarre M; Payza K; St-Onge S; Kamassah A; Morin PE; Projean D; Ducharme J; Roberts E
J Med Chem; 2000 Oct; 43(21):3878-94. PubMed ID: 11052793
[TBL] [Abstract][Full Text] [Related]
3. Factors influencing agonist potency and selectivity for the opioid delta receptor are revealed in structure-activity relationship studies of the 4-[(N-substituted-4-piperidinyl)arylamino]-N,N-diethylbenzamides.
Thomas JB; Herault XM; Rothman RB; Atkinson RN; Burgess JP; Mascarella SW; Dersch CM; Xu H; Flippen-Anderson JL; George CF; Carroll FI
J Med Chem; 2001 Mar; 44(6):972-87. PubMed ID: 11300879
[TBL] [Abstract][Full Text] [Related]
4. Probes for narcotic receptor mediated phenomena. 23. Synthesis, opioid receptor binding, and bioassay of the highly selective delta agonist (+)-4-[(alpha R)-alpha-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]- N,N-diethylbenzamide (SNC 80) and related novel nonpeptide delta opioid receptor ligands.
Calderon SN; Rice KC; Rothman RB; Porreca F; Flippen-Anderson JL; Kayakiri H; Xu H; Becketts K; Smith LE; Bilsky EJ; Davis P; Horvath R
J Med Chem; 1997 Feb; 40(5):695-704. PubMed ID: 9057856
[TBL] [Abstract][Full Text] [Related]
5. Probes for narcotic receptor-mediated phenomena. 25. Synthesis and evaluation of N-alkyl-substituted (alpha-piperazinylbenzyl)benzamides as novel, highly selective delta opioid receptor agonists.
Katsura Y; Zhang X; Homma K; Rice KC; Calderon SN; Rothman RB; Yamamura HI; Davis P; Flippen-Anderson JL; Xu H; Becketts K; Foltz EJ; Porreca F
J Med Chem; 1997 Aug; 40(18):2936-47. PubMed ID: 9288176
[TBL] [Abstract][Full Text] [Related]
6. N,N-Diethyl-4-[(3-hydroxyphenyl)(piperidin-4-yl)amino] benzamide derivatives: the development of diaryl amino piperidines as potent delta opioid receptor agonists with in vivo anti-nociceptive activity in rodent models.
Jones P; Griffin AM; Gawell L; Lavoie R; Delorme D; Roberts E; Brown W; Walpole C; Xiao W; Boulet J; Labarre M; Coupal M; Butterworth J; St-Onge S; Hodzic L; Salois D
Bioorg Med Chem Lett; 2009 Nov; 19(21):5994-8. PubMed ID: 19800791
[TBL] [Abstract][Full Text] [Related]
7. (+/-)-4-[(N-allyl-cis-3-methyl-4-piperidinyl)phenylamino]-N,N-diethylbenzamide displays selective binding for the delta opioid receptor.
Thomas JB; Herault XM; Rothman RB; Burgess JP; Mascarella SW; Xu H; Horel RB; Dersch CM; Carroll FI
Bioorg Med Chem Lett; 1999 Oct; 9(20):3053-6. PubMed ID: 10571174
[TBL] [Abstract][Full Text] [Related]
8. Biaryl piperidines as potent and selective delta opioid receptor ligands.
Liras S; McHardy SF; Allen MP; Segelstein BE; Heck SD; Bryce DK; Schmidt AW; Vanase-Frawley M; Callegari E; McLean S
Bioorg Med Chem Lett; 2010 Jan; 20(2):503-7. PubMed ID: 20015649
[TBL] [Abstract][Full Text] [Related]
9. Diaryldimethylpiperazine ligands with mu- and delta-opioid receptor affinity: Synthesis of (+)-4-[(alphaR)-alpha-(4-allyl-(2S,5S)-dimethylpiperazin-1-yl)-(3-hydroxyphenyl)methyl]-N-ethyl-N-phenylbenzamide and (-)-4-[(alphaR)-alpha-(2S,5S)-dimethylpiperazin-1-yl)-(3-hydroxyphenyl)methyl]-N-ethyl-N-phenylbenzamide.
Kim IJ; Ullrich T; Janetka JW; Furness MS; Jacobson AE; Rothman RB; Dersch CM; Flippen-Anderson JL; George C; Rice KC
Bioorg Med Chem; 2003 Nov; 11(22):4761-8. PubMed ID: 14556791
[TBL] [Abstract][Full Text] [Related]
10. Probes for narcotic receptor-mediated phenomena. 27. Synthesis and pharmacological evaluation of selective delta-opioid receptor agonists from 4-[(alphaR)-alpha-(2S,5R)-4-substituted-2, 5-dimethyl-1-piperazinyl-3-methoxybenzyl]-N,N-diethylbenzamides and their enantiomers.
Furness MS; Zhang X; Coop A; Jacobson AE; Rothman RB; Dersch CM; Xu H; Porreca F; Rice KC
J Med Chem; 2000 Aug; 43(16):3193-6. PubMed ID: 10956228
[TBL] [Abstract][Full Text] [Related]
11. 4-Piperidin-4-ylidenemethyl-benzamides as δ-opioid receptor agonists for CNS indications: identifying clinical candidates.
Dantzman CL; King MM; Ernst GE; Wang X; McCauley JP; Andisik DW; Brush K; Bui KH; Frietze W; Hoesch V; Liu J; Palmer WE; Spear N; Hudzik TJ; Wesolowski SS
Bioorg Med Chem Lett; 2012 Jan; 22(2):1174-8. PubMed ID: 22197137
[TBL] [Abstract][Full Text] [Related]
12. A continuous flow process using a sequence of microreactors with in-line IR analysis for the preparation of N,N-diethyl-4-(3-fluorophenylpiperidin-4-ylidenemethyl)benzamide as a potent and highly selective δ-opioid receptor agonist.
Qian Z; Baxendale IR; Ley SV
Chemistry; 2010 Nov; 16(41):12342-8. PubMed ID: 20859972
[TBL] [Abstract][Full Text] [Related]
13. Optically pure (-)-4-[(N-allyl-3-methyl-4-piperidinyl)phenyl-amino]-N,N-diethylbenzami de displays selective binding and full agonist activity for the delta opioid receptor.
Thomas JB; Atkinson RN; Herault XM; Rothman RB; Mascarella SW; Dersch CM; Xu H; Horel RB; Carroll FI
Bioorg Med Chem Lett; 1999 Dec; 9(23):3347-50. PubMed ID: 10612597
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
[TBL] [Abstract][Full Text] [Related]
15. Identification of the first trans-(3R,4R)- dimethyl-4-(3-hydroxyphenyl)piperidine derivative to possess highly potent and selective opioid kappa receptor antagonist activity.
Thomas JB; Atkinson RN; Rothman RB; Fix SE; Mascarella SW; Vinson NA; Xu H; Dersch CM; Lu Y; Cantrell BE; Zimmerman DM; Carroll FI
J Med Chem; 2001 Aug; 44(17):2687-90. PubMed ID: 11495579
[TBL] [Abstract][Full Text] [Related]
16. De novo design, synthesis, and biological activities of high-affinity and selective non-peptide agonists of the delta-opioid receptor.
Liao S; Alfaro-Lopez J; Shenderovich MD; Hosohata K; Lin J; Li X; Stropova D; Davis P; Jernigan KA; Porreca F; Yamamura HI; Hruby VJ
J Med Chem; 1998 Nov; 41(24):4767-76. PubMed ID: 9822547
[TBL] [Abstract][Full Text] [Related]
17. Discovery of N-{4-[(3-hydroxyphenyl)-3-methylpiperazin-1-yl]methyl-2-methylpropyl}-4-phenoxybenzamide analogues as selective kappa opioid receptor antagonists.
Kormos CM; Jin C; Cueva JP; Runyon SP; Thomas JB; Brieaddy LE; Mascarella SW; Navarro HA; Gilmour BP; Carroll FI
J Med Chem; 2013 Jun; 56(11):4551-67. PubMed ID: 23651437
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and binding affinities of 4-diarylaminotropanes, a new class of delta opioid agonists.
Boyd RE; Carson JR; Codd EE; Gauthier AD; Neilson LA; Zhang SP
Bioorg Med Chem Lett; 2000 May; 10(10):1109-11. PubMed ID: 10843229
[TBL] [Abstract][Full Text] [Related]
19. Novel trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidines as mu opioid receptor antagonists with improved opioid receptor selectivity profiles.
Le Bourdonnec B; Barker WM; Belanger S; Wiant DD; Conway-James NC; Cassel JA; O'Neill TJ; Little PJ; DeHaven RN; DeHaven-Hudkins DL; Dolle RE
Bioorg Med Chem Lett; 2008 Mar; 18(6):2006-12. PubMed ID: 18313920
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and pharmacological evaluation of SNC80 analogues with a bridged piperazine ring.
Holl R; Jung B; Schepmann D; Humpf HU; Grünert R; Bednarski PJ; Englberger W; Wünsch B
ChemMedChem; 2009 Dec; 4(12):2111-22. PubMed ID: 19827086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
